NCT00596596View on ClinicalTrials.gov

Trial to Evaluate the Efficacy and Safety of R093877 in Patients With Chronic Idiopathic Constipation

PHASE2CompletedINTERVENTIONAL
Enrollment

313

Participants

Timeline

Start Date

September 30, 1996

Primary Completion Date

June 30, 1997

Study Completion Date

June 30, 1997

Conditions
Constipation
Interventions
DRUG

prucalopride

0,5 mg once daily

DRUG

prucalopride

1 mg once daily

DRUG

2 mg prucalopride

2 mg once daily

DRUG

4 mg prucalopride

4 mg once daily

OTHER

Placebo

placebo once daily

Sponsors

Lead Sponsor

Movetis
All Listed Sponsors
lead

Movetis

INDUSTRY